Jackson Square Partners LLC Sells 67,183 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Jackson Square Partners LLC trimmed its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 16.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 336,250 shares of the company’s stock after selling 67,183 shares during the quarter. Ryan Specialty accounts for 2.3% of Jackson Square Partners LLC’s portfolio, making the stock its 19th largest holding. Jackson Square Partners LLC’s holdings in Ryan Specialty were worth $21,574,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Natixis Advisors LLC acquired a new position in shares of Ryan Specialty in the 3rd quarter worth approximately $2,021,000. Intech Investment Management LLC grew its position in shares of Ryan Specialty by 61.8% during the 3rd quarter. Intech Investment Management LLC now owns 16,544 shares of the company’s stock worth $1,098,000 after buying an additional 6,316 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after buying an additional 286,380 shares during the period. Great Valley Advisor Group Inc. acquired a new position in shares of Ryan Specialty in the 3rd quarter valued at $346,000. Finally, Loomis Sayles & Co. L P lifted its stake in Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after buying an additional 286 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the transaction, the director now directly owns 35,609 shares of the company’s stock, valued at $2,349,837.91. The trade was a 49.57 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the firm’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 in the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

RYAN has been the topic of a number of research analyst reports. Royal Bank of Canada dropped their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Morgan Stanley started coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Finally, UBS Group lifted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $75.27.

Ryan Specialty Stock Up 2.0 %

Shares of NYSE RYAN opened at $72.44 on Tuesday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97. The company has a 50 day simple moving average of $68.27 and a 200 day simple moving average of $68.07. The firm has a market cap of $18.97 billion, a PE ratio of 104.99, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.66%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio is currently 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.